Restart of the National Medicines Policy Review – Further Consultation on a Revised Draft of the National Medicines Policy
Page last updated: 17 August 2022
The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised draft of the National Medicines Policy (NMP).
Finalisation of the Review was extended until after the recent Federal Election in May 2022.
The Minister for Health and Aged Care, the Hon. Mark Butler MP has reappointed Professor Michael Kidd AM as the sole reviewer to complete the Review and provide a final report to Government later this year.
Provide your feedback on the draft NMP
Stakeholders will have the opportunity to engage and provide feedback on the revised draft of the 2022 NMP through a range of channels. The diverse perspectives, experience and knowledge of all stakeholders is highly valued and will contribute to the report to Government and finalisation of the 2022 NMP.
To access the revised draft NMP 2022 and supporting documents, including an online survey, please visit Revised Draft of the National Medicines Policy Consultation Page.
The consultation survey will be open for six weeks from 17 August 2022 until 27 September 2022 at 11:59pm.
The online consultation survey will be accompanied by a public stakeholder forum that will be scheduled during September 2022.
Professor Michael Kidd will also engage in open targeted consultations with a range of key stakeholder groups including: the medicines industry; consumers; Aboriginal and Torres Strait Islanders; prescribers; pharmacy sector; and the states and territories.
Further advice on timing and how to register interest for the public stakeholder forum and open targeted consultations will be published within the coming week on the Revised Draft of the National Medicines Policy Consultation Page.
For enquiries about the Review please email NMP@health.gov.au.